FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to cardiology and concerns treatment of such diseases of heart as heart arrhythmia, ischemia and myocardial infarction. For this purpose taliporfin in effective doses is administered.
EFFECT: method provides effective treatment of the specified pathology at the expense of antiarrhytmic taliporfin action, and also its abilities to reduce a zone of myocardium ischemia and to enlarge NO synthesis.
5 ex, 6 tbl, 9 dwg
Title | Year | Author | Number |
---|---|---|---|
2-MERCAPTOBENZIMIDAZOLE DERIVATIVES SHOWING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 1995 |
|
RU2136667C1 |
AGENT POSSESSING ANTIARRHYTHMIC ACTION | 2019 |
|
RU2700263C1 |
APPLICATION OF KAURAN COMPOUNDS FOR MEDICINES PRODUCTION | 2004 |
|
RU2345761C2 |
AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
AGENT FOR INCREASING RESISTANCE OF HEART TO ARRYTHMOGENIC ACTION OF ISCHAEMIA AND REPERFUSION | 2014 |
|
RU2587783C1 |
CARDIOPROTECTIVE AND ANTIARRHYTHMIC MEDICINE | 2022 |
|
RU2783444C1 |
ANTIARRHYTHMIC DRUG | 2017 |
|
RU2664668C1 |
MEANS FOR TREATMENT OF VIOLATIONS INVOLVING RIANODIN RECEPTORS MODULATION | 2013 |
|
RU2644350C2 |
AGENT POSSESSING ANTIARRHYTHMIC, ANTIFIBRILLATORY, ANTI-ISCHEMIC ACTION, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2477130C1 |
AGENT EXHIBITING ANTIARRHYTHMIC ACTIVITY | 2014 |
|
RU2565404C1 |
Authors
Dates
2009-03-27—Published
2001-02-28—Filed